U.S. Court of Appeals for the Federal Circuit
Glaxosmithkline LLC v. Teva Pharmaceuticals USA, Inc.
This writing
- Type
- Opinion
- Filed
- Aug. 5, 2021
- Case
- Glaxosmithkline LLC v. Teva Pharmaceuticals USA, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 18-1976 Document: 187 Page: 1 Filed: 08/05/2021 United States Court of Appeals for the Federal Circuit ______________________ GLAXOSMITHKLINE LLC, SMITHKLINE BEECHAM (CORK) LIMITED, Plaintiffs-Appellants v. TEVA PHARMACEUTICALS USA, INC., Defendant-Cross-Appellant ______________________ 2018-1976, 2018-2023 ________…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.